Advertisement
Screener

EXAGEN INC. (XGN) Material Contracts

EXAGEN INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-04: Form 10-Q; Exhibit 10.1; Description Lease by and between LOA 26 LP, a Delaware limited partnership, by and through View 26 LLC, its General Partner and the Company.
  • 2026-05-11: Form 10-Q; Exhibit 10.1; Description Amended & Restated Non-Employee Director Compensation Program.
  • 2026-03-10: Form 10-K; Exhibit 10.43; Description First Amendment to Credit Agreement and Guaranty, dated March 6, 2026, by and among the Company and Perceptive Credit Holdings IV, LP..
  • 2025-07-17: Form 8-K; Exhibit 10.1; Description Amended & Restated Non-Employee Director Compensation Program.
FiledFormExhibitDescription
2026-08-0410-Q10.1Lease by and between LOA 26 LP, a Delaware limited partnership, by and through View 26 LLC, its General Partner and the Company
2026-05-1110-Q10.1Amended & Restated Non-Employee Director Compensation Program
2026-03-1010-K10.43First Amendment to Credit Agreement and Guaranty, dated March 6, 2026, by and among the Company and Perceptive Credit Holdings IV, LP.
2025-07-178-K10.1Amended & Restated Non-Employee Director Compensation Program
2025-04-288-K10.2Security Agreement, dated April 25, 2025, by and among the Company and Perceptive Credit Holdings IV, LP.
2025-04-288-K10.1Credit Agreement and Guaranty, dated April 25, 2025, by and among the Company and Perceptive Credit Holdings IV, LP.
2024-08-0510-Q10.2Exagen Inc. Amended and Restated Executive Change in Control and Severance Plan.
2024-08-028-K10.1Employment Agreement, dated as of September 1, 2024, by and between the Company and Jeffrey Black.
2024-05-1310-Q10.1Fourth Amendment to Loan and Security Agreement dated April 12, 2024, by and among Innovatus Life Sciences Lending I, LP, other lenders and the Company.
2023-12-118-K10.1Consulting Agreement, dated as of December 6, 2023, by and between the Company and Mark Hazeltine.
2023-11-1310-Q10.2Exagen Inc. Clawback Policy.
2023-11-1310-Q10.1Assignment and Assumption Agreement, by and among Liberty Vista, L.P., Mindera Corporation and the Company.
2023-05-048-K10.1Third Amendment to Loan and Security Agreement dated April 28, 2023, by and among Innovatus Life Sciences Lending I, LP, other lenders and the Company.
2022-12-058-K10.1Consulting Agreement, dated as of December 5, 2022, by and between the Company and Debra Zack, M.D., Ph.D.
2022-10-208-K10.2Severance Agreement, dated as of October 14, 2022, by and between the Company and Fortunato Ron Rocca.
2022-10-208-K10.1Employment Agreement, dated as of October 16, 2022, by and between the Company and John Aballi.
2022-05-1110-Q10.1Exagen Inc. Amended and Restated Executive Change in Control and Severance Plan.
2022-04-288-K10.1Exagen Inc. Amended and Restated Executive Change in Control and Severance Plan
2021-11-1010-Q10.6Letter Agreement, dated September 28, 2021, by and between the Company and Prometheus Laboratories Inc.
2021-11-1010-Q10.5Second Amendment to Loan and Security Agreement dated November 1, 2021, by and among Innovatus Life Sciences Lending I, LP, other lenders and the Company.
2021-11-1010-Q10.4First Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated October 19, 2021, by and between RGS Properties and the Company.
2021-11-1010-Q10.3Fifth Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated October 19, 2021, by and between RGS Properties and the Company.
2021-11-1010-Q10.2Second Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated October 11, 2021, by and between Liberty Vista and the Company.
2021-11-1010-Q10.1Sublease Agreement, dated August 19, 2021, by and between Plum Healthcare Group, LLC and the Company.
2021-08-0910-Q10.1Amendment #4 to Co-Promotion Agreement, dated June 30, 2021
2021-03-1610-K10.46Executive Change in Control Severance Plan.
2021-03-1610-K10.34First Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated January 6, 2021, by and between Liberty Vista and the Registrant.
2021-03-1610-K10.25Amendment #3 to Co-Promotion Agreement, dated December 23, 2020, by and between Janssen Biotech, Inc. and the Registrant.
2021-03-1610-K10.5Form of Restricted Stock Unit Agreement under Exagen Inc. 2019 Incentive Award Plan.
2020-11-1010-Q10.1Acknowledgement Letter to Loan and Security Agreement, by and between Innovatus Life Sciences Lending I, LP and the Registrant.
2020-07-2810-Q10.2Amendment #2 to Co-Promotion Agreement, dated June 18, 2020, by and between Janssen Biotech, Inc. and the Registrant.
2020-07-2810-Q10.1Amendment #1 to Co-Promotion Agreement, dated January 1, 2019, by and between Janssen Biotech, Inc. and the Registrant.
2020-03-2510-K10.41Offer Letter dated February 21, 2020, by and between Debra Zack, MD Ph.D. and the Registrant.
2020-03-2510-K10.36First Amendment to Loan and Security Agreement with Innovatus Life Sciences Lending I, LP dated November 19, 2019.
2020-03-2510-K10.33Standard Industrial/Commercial Multi-Tenant Lease, dated March 17, 2020 by and between RGS Properties and the Registrant.
2020-03-2510-K10.32Extension of Lease to Standard Industrial/Commercial Single-Tenant Lease, dated March 12, 2020, by and between Liberty Vista and the Registrant.
2020-03-2510-K10.31First Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated August 2, 2017, by and between Geiger Court, LLC and the Registrant.
2020-03-2510-K10.29Fourth Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated March 16, 2020, by and between RGS Properties and the Registrant.
2020-03-2510-K10.28Third Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated June 16, 2017, by and between RGS Properties and the Registrant.
2020-03-2510-K10.27Second Amendment to Standard Industrial/Commercial Multi-Tenant Lease, dated April 29, 2016, by and between RGS Properties and the Registrant.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Freenome, Inc. (FRNM)United States$0.143B
BIODESIX INC (BDSX)United States$0.312B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45